Best Medical Device Engineering Podcasts (2025)

1
Data-Driven Insights Reveal The Growth Engines Powering 2026 Life Sciences 28:46

Play Pause

17m ago28:46

28:46

In this special In Vivo podcast episode, executive editor Lucie Ellis-Taitt is joined by an expert panel of Citeline journalists – Ashley Yeo, David Wild, Jessica Merrill and data journalist Edwin Elmhirst – to explore the trends set to reshape the biopharma and medtech sectors as we head into 2026.By Citeline

1
S6E46 Rick James | ANSYS & Engineering Simulation 50:14

1d ago50:14

50:14

Send us a text Rick James is the Chief Executive Officer at SimuTech Group, North America’s largest ANSYS Elite Channel Partner. With a 25+ year career at the intersection of mechanical and electrical engineering, he has spearheaded multi-million dollar projects, FEA analyses, drop testing, and reliability-driven design efforts in industries from s…

1
EY's Arda Ural on IPOs, Financial Markets and Tarrifs 35:02

3h ago35:02

35:02

After two of the toughest years in biotech history, are we finally seeing a turnaround? EY's Arda Ural discusses the long-awaited recovery in biotech IPOs, the evolving capital markets landscape and how tariffs and Trump RX are reshaping biopharma supply chains. In this wide-ranging conversation, Ural unpacks the three key factors driving IPO recov…

1
Datamonitor Healthcare Podcast: ESMO 2025 31:28

2h ago31:28

31:28

Summer Colling and Emma Wille speak with Nkiru Ibeanu, Anna Simmons, and David Dahan from the oncology team about some of the most exciting data presented at the 2025 European Society For Medical Oncology conference.By Citeline

1
AI in Higher Education: Lessons from Georgia Tech | Raheem Beyah 1:17:32

11h ago1:17:32

1:17:32

In this episode of Badass Leaders, Raheem Beyah, Georgia Tech's Provost and Executive Vice President for Academic Affairs joins Angela to talk about innovation, mentorship, and the evolution of leadership in higher education. Born and raised in Atlanta, Raheem shares how his grandmother's biscuits and a childhood love of video games first sparked h…

1
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 14:53

8d ago14:53

14:53

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年11月1日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本次要闻: 辉瑞对Metsera的坚定收购计划；礼来公司肥胖症治疗领域的强劲势头；默克公司MFN协议谈判进展；诺华公司干燥综合征研究的积极成果；以及中国对美国创新领域施加的日益增大的压力。Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-2K33BM6BLBDU7JH7QMETUXUKPE/Playlist: on.soundcloud.…

1
Scrip's Five Must-Know Things - Nov. 10, 2025 15:20

2h ago15:20

15:20

Audio roundup of selected biopharma industry content from Scrip over the business week ended November 1, 2025. In this episode: Pfizer’s unwavering pursuit of Metsera; Lilly’s obesity momentum; Merck & Co.’s MFN negotiations; Novartis’s promising Sjögren’s results; and the rising Chinese pressure on US innovation. Story links: https://insights.cite…

1
Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center 35:39

3h ago35:39

35:39

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs take a deep dive into the circumstances of George Tidmarsh’s departure as director of the US Food and Drug Administration’s Center for Drug Evaluation and Research (:30). They also consider the long-term impact o…

1
S6E45 Jeremy Jarrett | Legal Advice & Strategy for Starting An Engineering Business 50:52

17h ago50:52

50:52

Send us a text Our guest today is Jeremy Jarrett, an attorney at Sacks Tierney in Scottsdale, Arizona, where he focuses on corporate, securities, and finance law. Jeremy brings more than 10 years of experience advising businesses on complex transactions, including mergers and acquisitions, spin-offs, recapitalizations, commercial lending, and equit…

1
Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology 10:09

12h ago10:09

10:09

Join Sarah Anderson, Therapeutic Strategy Director, Oncology at Novotech, and Izabela Chmielewska from Citeline as they explore how next-generation immuno-oncology strategies are reshaping cancer research. From emerging modalities to smarter trial design and evolving regulatory expectations, discover what’s driving the next wave of innovation in on…

1
Badass Best of: How to Leave a Legacy That Lasts 20:27

12d ago20:27

20:27

What does it really mean to leave a legacy? In this Badass Leaders Podcast "Best Of" episode, we bring together powerful insights from leaders who are redefining what impact looks like. Together, these guests offer perspectives that challenge traditional ideas of success and invite us to think bigger about purpose, service, and the mark we leave be…

1
Copyright Piracy Costs America up to $71 Billion: Hollywood Producer Ruth Vitale Speaks Out 40:07

2d ago40:07

40:07

Send us a text Ruth Vitale, Oscar-winning producer and CEO of Creative Future, reveals the devastating impact of copyright piracy on America's entertainment workforce. Piracy costs the economy up to $71 billion annually and threatens 560,000 jobs across film and television. Ruth explains how small business IP protection matters for the 122,000 comp…

1
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 12:32

14d ago12:32

12:32

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月31日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本次要闻: 本期要闻——第三季度并购交易回暖；诺华收购Avidity后并购火力依旧；韩美制药肥胖症候选药物展现三期试验潜力；英伟达合作推动礼来人工智能计划；礼来收购Adverum强化基因疗法布局。Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-MQMX2YHSAVHBTJFR4RAEAYNFNQ/Playlist: on.sound…

1
Scrip's Five Must-Know Things - Nov. 4, 2025 13:00

4d ago13:00

13:00

Audio roundup of selected biopharma industry content from Scrip over the business week ended October 31, 2025. In this episode: third quarter dealmaking picks up; Novartis still has M&A firepower even after Avidity acquisition; Hanmi’s obesity contender shows Phase III promise; NVIDIA partnership progresses Lilly’s AI plans; and Lilly builds gene t…

1
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform 23:20

14d ago23:20

23:20

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the impact of the US Food and Drug Administration announcement that a comparative efficacy study is no longer a prerequisite for biosimilar approval (:35), as well as the upcoming guidance stating the interchangeability switching study r…

1
Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine 33:31

6d ago33:31

33:31

What if we could train AI to understand how stem cells become any cell type in the human body? In this episode of the In Vivo Podcast, host David Wild sits down with Micha Breakstone (CEO & Co-founder) and Samantha Dale Strasser (VP of Strategy) from Somite.AI to explore how their company is using foundation models to revolutionize cell therapy dev…

1
S6 E44 Ryan Stevenson | Working on Apple’s Vision Pro & Launching a Freelance Engineering Business 52:03

7d ago52:03

52:03

Send us a text Ryan Stevenson is a versatile mechanical engineer whose career spans high-profile tech companies, outdoor gear innovators, and entrepreneurial ventures. After earning his Master’s degree in Mechanical Engineering from Boise State University, Ryan launched into product development roles that combined advanced CAD, manufacturing engine…

1
Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space? 36:02

12d ago36:02

36:02

Joseph Haas, senior writer, Scrip, speaks to guest panelists Robert Darwin, partner, Sidley law firm, and Arda Ural, Americas Life Sciences Leader, EY.By Citeline

1
국내 바이오텍 펀딩 활성화를 위해 새로운 촉매제 필요 (Korean-language podcast) 3:42

18d ago3:42

3:42

스톤브릿지벤쳐스의 김현기 상무는 Scrip과의 인터뷰에서 벤처캐피탈의 국내 바이오 투심 회복을 제약하는 요인과 투자 고려사항, 전략 등을 이야기했습니다. https://insights.citeline.com/scrip/leadership/interviews/a-vc-perspective-on-korean-bioventures-new-catalysts-needed-to-jumpstart-activity-Z7IXGZWZVVGKFDPNOWNJJPMWLQ/Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini…

1
From Veteran Medic to CEO: Reinventing Yourself After PTSD | Suzy Wraines 1:43:44

13d ago1:43:44

1:43:44

In this powerful conversation, veteran and entrepreneur Suzy Wraines opens up about her journey from military medic to trauma-informed business coach. She shares how growing up in remote Alaska built her resilience, how joining the Army at 29 reshaped her identity, and how ignoring her trauma nearly cost her her health and purpose. Suzy explains th…

1
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 17:28

22d ago17:28

17:28

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月24日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本期聚焦柏林欧洲医学肿瘤学会会议的新成果：Enhertu在早期乳腺癌中的应用；Padcev/Keytruda在膀胱癌领域的突破；Pluvicto的III期试验成功；Trodelvy与Datroway在乳腺癌治疗领域的较量；默克公司为乳腺癌治疗带来新希望。Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-EWX3A6U4TBE5NPDYX…

1
Scrip's Five Must-Know Things - Oct. 27, 2025 17:13

11d ago17:13

17:13

Audio roundup of selected biopharma industry content from Scrip over the business week ended October 24, 2025. In this episode we focus on the most significant results presented at the European Society for Medical Oncology meeting in Berlin: Enhertu in early-stage breast cancer; Padcev/Keytruda in bladder cancer; Phase III wins for Pluvicto; Trodel…

1
Drug Fix: Another FDA Inspection Reorg, Industry Navigating New DTC Landscape 39:44

13d ago39:44

39:44

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs explain the reasons for the US Food and Drug Administration’s planned “Simple Reform” of its inspection group, including the move away from specialized teams (:44). They also consider industry’s current thinking …

1
S6 E43 Greg Mark | Founding Markforged & Backflip.ai 54:04

14d ago54:04

54:04

Send us a text This episode is a rerun. In this fascinating episode of Being an Engineer, our host Aaron Moncur sits down with Greg Mark, a visionary entrepreneur who revolutionized 3D printing with Markforged and is now transforming design workflows with his AI company, Backflip. Greg shares insights into his entrepreneurial journey, technological…

1
Winning Biotech Investors Through Strategic Partnerships and Trial Innovation 45:59

26d ago45:59

45:59

Biotech funding is tougher than ever, but some companies still win big. Join Claire Riches, VP, Clinical Solutions, Citeline and Alistair McDonald, CEO of Worldwide Clinical Trials as they reveal insider strategies for securing investors, navigating partnerships, and turning innovative science into real-world success.View the video series and find …

1
AI Adoption Moves At The Speed of Trust 47:00

17d ago47:00

47:00

Send us a text Award-winning educator and IP advocate Daryl Lim joins Bruce Berman to explore the intersection of artificial intelligence and intellectual property education. Broadcasting from Singapore, Daryl shares his global perspective on how AI is reshaping IP frameworks, from the $1.5 billion Anthropic settlement to the emergence of new data …

1
From Incarceration to Inspiration: How a 30-Year Prison Sentence into Purpose | Brian Rowe 2:01:35

23d ago2:01:35

2:01:35

In 2010, Brian Rowe was sentenced to 30 years in federal prison for a nonviolent drug conspiracy. Most people would have seen that as the end. Brian saw it as a turning point. In this episode, he shares how he transformed pain into purpose, turned crisis into opportunity, and rebuilt his life to become a business catalyst, AWS Partner, and communit…

1
Innovating Autoimmune Treatment with In Vivo CAR-T 9:50

27d ago9:50

9:50

As the potential of in vivo CAR-T therapy moves closer to clinical reality, biotech innovators are reimagining what’s possible in autoimmune disease. With groundbreaking scientific advances and evolving regulatory perspectives, this next generation of cell therapy could redefine how immune-mediated conditions are treated. In this episode, Pete Robi…

1
DE Editors' Chat: AU, Ansys Simulation World, Market-Changing Acquisitions, Preview of the DE Summit, and More 20:22

17d ago20:22

20:22

DE editors Kenneth Wong and Brian Albright discuss what they saw at the recent conferences, the impact of recent acquisitions by Synopsys and Siemens, and the upcoming DE Design and Simulation SummitBy Kenneth Wong

1
How Olon’s fully integrated, end-to-end ADC capabilities drive quality and scale 15:17

28d ago15:17

15:17

Hear experts Matthieu Culié and Alessandro Agosti as they discuss how Olon stands out in a competitive landscape through its fully integrated end-to-end ADC manufacturing expertise, global operations, impurity control and strategic facilities.By Citeline

1
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 16:22

29d ago16:22

16:22

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月17日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本次要闻: 大型药企仍看好细胞与基因疗法前景；ESMO会议关注焦点；科伦制药TROP2抗体药物偶联物创全球首例；强生预期与白宫政策保持一致；BioFuture会议揭示行业不确定性。Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-ADAR4VZIGRFIFCOMXI7UTZS76U/Playlist: on.soundcloud.com…

1
Scrip's Five Must-Know Things - Oct. 20, 2025 16:29

29d ago16:29

16:29

Audio roundup of selected biopharma industry content from Scrip over the business week ended October 17, 2025. In this episode: big pharma still sees value in cell and gene therapy; what to look out for at ESMO; world first for Kelun’s TROP2 ADC; J&J expects alignment with White House policies; industry uncertainties aired at BioFuture meeting. Sto…

1
JPR: AI Processor Market Heats Up 18:57

27d ago18:57

18:57

Analyst Jon Peddie discusses NVIDIA's investment in Intel, challengers to NVIDIA and AMD, natural language in design and simulation software, and moreBy Kenneth Wong

1
Drug Fix: US FDA Involved In Astra Zeneca’s Drug Pricing Deal, DOJ’s Off-Label Promotion Policy 29:23

1M ago29:23

29:23

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs discuss the reasons US Food and Drug Administration Commissioner Martin Makary could have helped negotiate the Most Favored Nation drug pricing deal with Astra Zeneca (:30) and the deal’s potential impact on the 340B program (16:35). They…

1
Adalvo: Exploring European B2B Pharma’s Next Steps 14:41

23d ago14:41

14:41

Adalvo: Exploring European B2B Pharma’s Next Steps by CitelineBy Citeline

1
S6E42 Ramzi Marjaba | From Idea to Approval: Persuasion for Engineers 54:18

21d ago54:18

54:18

Send us a text Ramzi Marjaba is a seasoned Solution Engineer and consultant currently with Veeam Software, working remotely from Ottawa since March 2025. Prior to this, he spent nearly four years as a Senior Solution Specialist at Keysight Technologies, managing Eastern Canada accounts and mentoring both SEs and account executives. Earlier in his c…

1
Lupus Clinical Development Enters a New Era of Innovation 35:32

1M ago35:32

35:32

Join host David Wild as he speaks with Stacie Bell, chief clinical research officer at Lupus Therapeutics, about the dramatic transformation happening in lupus drug development. From a field once avoided by pharma companies to one generating unprecedented excitement, Bell discusses how her organization's 62-center network is revolutionizing clinica…

1
Exploring B2B Adalvo’s asset-light model and the future of pharma 9:23

1M ago9:23

9:23

Listen now: Adalvo – advancing pharma with private equity and an asset-light modelBy Citeline

1
Essential Pharma – Following A Patient First Philosophy 17:29

1M ago17:29

17:29

In Vivo spoke with Emma Johnson, CEO of Essential Pharma, to discuss the company's strategic priorities and plans for growth as it expands its portfolio in rare diseases.By Citeline

1
Final call to join us at PDX 2025! 1:59

22d ago1:59

1:59

Send us a text This is your final call to join us at PDX 2025 – The Product Development Expo, happening October 21–22 in Phoenix, Arizona. PDX is not your typical conference—it’s a hands-on training experience built specifically for engineers who design and develop physical products. Learn directly from industry experts in areas like GD&T, DFM, aut…

1
The $100M Journey from Discovery to Device | Nassir Mokarram 1:55:57

22d ago1:55:57

1:55:57

What if treating brain cancer wasn't about destroying tumors, but redirecting them? In this captivating episode, Dr. Nassir Mokarram—Director of Venture Investments at the Emory Endowment and a Georgia Tech "40 Under 40" honoree—shares the remarkable story behind the "Tumor Monorail," a groundbreaking medical device designed to guide brain tumors a…

1
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 15:50

1M ago15:50

15:50

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月10日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本次要闻: 生物制药融资重燃乐观情绪；CAR-T疗法适应症扩大将考验医疗体系承载力；高德美在皮肤科领域表现超出预期；安进推出面向患者的Repatha直接销售计划；Datroway在乳腺癌领域取得生存期突破。Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-JZ326HAB2ZHB7E3Z5PNIUBITQQ/Playlist: on.s…

1
Scrip's Five Must-Know Things - Oct. 14, 2025 15:57

1M ago15:57

15:57

Audio roundup of selected biopharma industry content from Scrip over the business week ended October 10, 2025. In this episode: biopharma financing regaining optimism; larger CAR-T indications to strain healthcare capacity; Galderma punching above weight in dermatology; Amgen’s direct-to-patient Repatha program; and Datroway’s survival success in b…

1
Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases 36:51

1M ago36:51

36:51

Cereno Scientific CEO Sten Sörensen discusses how his company is repurposing a 60-year-old epilepsy drug as a potential game-changer for pulmonary arterial hypertension and idiopathic pulmonary fibrosis. Learn about their promising Phase IIa results that showed improved heart function and reduced mortality risk, the FDA fast track designation they …

1
S6E41 James Davis | Living in Ukraine for $12/Day to Become An Engineer 1:01:04

1M ago1:01:04

1:01:04

Send us a text James Davis, widely recognized as FluxBench, has built a following by making electronics approachable, fun, and practical. With a mission to “keep the magic smoke inside the components where it belongs,” James is passionate about teaching engineers, makers, and hobbyists how to move beyond simple projects and start creating productio…

1
Patents Don't Block Innovation, Ignorance Does 42:01

1M ago42:01

42:01

Send us a text Join host Bruce Berman for an illuminating conversation with Henry Hadad, Head of Intellectual Property Rights at Bristol-Myers Squibb. This episode explores how intellectual property education and strong patent protection drive medical breakthroughs while addressing common misconceptions about IP rights. Hadad shares his unique jour…

1
The #1 Mistake Leaders Make in Reputation Management (and How to Avoid It) | Aimee Christian 1:11:12

1M ago1:11:12

1:11:12

Host Angela Gill Nelms sits down with Aimee Christian, a former biopharma executive who boldly walked away from a 25-year corporate career to design a life and career on her own terms. Now a Professor of the Practice at Boston University, President of the Massachusetts Society for Medical Research, and CEO of Yes Communications, Aimee opens up abou…

1
Defining the Next Era of Disruption 20:24

1M ago20:24

20:24

By Citeline

1
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.7, 2025 13:37

1M ago13:37

13:37

By Citeline

1
Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes Baiao 22:11

1M ago22:11

22:11

Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes BaiaoThe Association of the European Self-Care Industry, or AESGP, has launched a digital platform that brings together inspiring self-care initiatives from across Europe. Launched to coincide with International Self-Care Day 2025, AESGP’s Self-Care Insight and Inspire pla…